Optimizing strain performance for commercialization

Van derden

17/07/24

Join Synonym, in collaboration with EV Biotech, Vectron Biosolutions, SynBioBeta and Enduro Genetics, for an insightful discussion on the critical role of strain engineering in the commercialization of bioproducts. Synonym and BCG’s recent report reveals that economies of scale alone are not sufficient for commercializing industrial bioproducts. Optimized strains designed for scale are pivotal for unlocking the massive potential of biomanufacturing in the coming decades. Our expert panel will explore the significance of strain optimization and its impact on increasing productivity, enhancing product quality, and achieving cost efficiency in biomanufacturing processes. We look forward to seeing you on July 17th!

📅 Date: July 17, 2024
🕒 Time: 4pm to 5pm CET
📍 Online

Register here